GIANNINI, CARLO
GIANNINI, CARLO
Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'
A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector
2003 Giannini C; Morosan S; Tralhao JG; Guidotti JE; Battaglia S; Mollier K; Hannoun L; Kremsdorf D; Gilgenkrantz H; Charneau P
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV
2003 P. Caini; C. Tosti Guerra; F. Giannelli; G. Buzzelli; E. Di Pietro; C. Giannini; L. Gragnani; V. Solazzo; M. Monti; G. Laffi; P. Gentilini; A.L. Zignego
ANALYSIS OF HCV INFECTION IN PATIENTS WITH B-CELL NON-HODGKINS-LYMPHOMA
1995 A.L. ZIGNEGO; C. FERRI; C. GIANNINI; F. CARACCIOLO; M. MONTI; L. LA CIVITA; G. CARECCIA; G. LONGOMBARDO; G. BELLESI; F. INNOCENTI; V. THIERS; P. GENTILINI
Analysis of HCV persistence in patients with sustained virological response
2006 C. Giannini; A. Petrarca; U. Arena; M. Monti; V. Solazzo; F. Giannelli; P. Caini; G. La Villa; G. Laffi; P. Gentilini; A.L. Zignego
Applicazione della metodica PCR (polymerase chain reaction) ed altre tecniche di biologia molecolare allo studio dell'infezione da virus C dell'epatite.
1995 C. Giannini; M. Monti; G. Careccia; P. Gentilini; A.L. Zignego
Association between HCV infection and monoclonal gammopathy (MG): A putative role for genotype 2a?
1996 Andreone P; Zignego AL; Cursaro C; Gramenzi A; Boni P; Cappelletti O; Giannini C; Giannelli F; Bernardi M; Gentilini P; Gasbarrini G
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment
2006 C. Giannini; F. Giannelli; A.L. Zignego
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia
2008 C. Giannini; A. Petrarca; M. Monti; U. Arena; P. Caini; V. Solazzo; L. Gragnani; S. Milani; G. Laffi; A.L. Zignego
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment
2002 F. Giannelli; M. Monti; P. Caini; S. Moscarella; R.G. Romanelli; C. Giannini; L. Gragnani; G. La Villa; G. Laffi; P. Gentilini; A.L. Zignego
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated?
2005 A. Petrarca; U. Arena; C. Giannini; M. Monti; V. Solazzo; F. Giannelli; P. Caini; G. La Villa; G. Laffi; A.L. Zignego
Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues
2001 Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Brechot P; Brechot C; Kremsdorf D
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?
2008 C. Giannini; L. Gragnani; A. Piluso; P. Caini; A. Petrarca; M. Monti; G. Laffi; A.L. Zignego
Can depletion of B-cells by anti-CD20 monoclonal antibody in HCV plus mixed cryoglobulinemia (MC) improve liver cirrhosis?
2007 A. Petrarca; L. Rigacci; C. Giannini; R. Caporale; P. Montalto; A. Bosi; G. Laffi; A.L. Zignego
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION
2001 P. Caini; A. Mazzocca; C. Cordella; C. Giannini; P. Pantaleo; R.G. Romanelli; M. E. Marrocchi; G. Laffi; P. Gentilini; A.L. Zignego.
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression
2001 P. Caini; A. Mazzocca; C. Cordella; C. Giannini; P. Pantaleo; R.G. Romanelli; M.E. Marrocchi; G. Laffi; P. Gentilini; A.L. Zignego
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression
2001 P. Caini; A. Mazzocca; C. Giannini; P. Pantaleo; R.G. Romanelli; L. Gragnani; G. Laffi; P. Gentilini; A.L. Zignego
Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells. Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells
1991 Capaccioli S.; Quattrone A.; Basi G.; Schiavone N.; Giannini C.
Chronic hepatitis C and B-cell non-Hodgkin's lymphoma
1996 C. Ferri; L. La Civita; M. Monti; C. Giannini; R. Cecchetti; F. Caracciolo; G.Longombardo; F.Lombardini; A.L. Zignego;
Clustering of the putative hepatitis C virus (HCV) receptor CD81 is necessary to promote B-cell proliferation and c-myc expression.
2000 A. Mazzocca; C. Cordella; C. Giannini; P. Pantaleo; R.G. Romanelli; G. Laffi; P. Gentilini; A.L. Zignego
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION.
2000 A. Mazzocca; F. Giannelli; R.G. Romanelli; S. Moscarella; P. Caini; C. Giannini; M. Monti; G. La Villa; G. Laffi. P. Gentilini; A.L. Zignego.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector | 2003 | Giannini C; Morosan S; Tralhao JG; Guidotti JE; Battaglia S; Mollier K; Hannoun L; Kremsdorf D; Gilgenkrantz H; Charneau P | |
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV | 2003 | P. Caini; C. Tosti Guerra; F. Giannelli; G. Buzzelli; E. Di Pietro; C. Giannini; L. Gragnani; V. Solazzo; M. Monti; G. Laffi; P. Gentilini; A.L. Zignego | |
ANALYSIS OF HCV INFECTION IN PATIENTS WITH B-CELL NON-HODGKINS-LYMPHOMA | 1995 | A.L. ZIGNEGO; C. FERRI; C. GIANNINI; F. CARACCIOLO; M. MONTI; L. LA CIVITA; G. CARECCIA; G. LONGOMBARDO; G. BELLESI; F. INNOCENTI; V. THIERS; P. GENTILINI | |
Analysis of HCV persistence in patients with sustained virological response | 2006 | C. Giannini; A. Petrarca; U. Arena; M. Monti; V. Solazzo; F. Giannelli; P. Caini; G. La Villa; G. Laffi; P. Gentilini; A.L. Zignego | |
Applicazione della metodica PCR (polymerase chain reaction) ed altre tecniche di biologia molecolare allo studio dell'infezione da virus C dell'epatite. | 1995 | C. Giannini; M. Monti; G. Careccia; P. Gentilini; A.L. Zignego | |
Association between HCV infection and monoclonal gammopathy (MG): A putative role for genotype 2a? | 1996 | Andreone P; Zignego AL; Cursaro C; Gramenzi A; Boni P; Cappelletti O; Giannini C; Giannelli F; Bernardi M; Gentilini P; Gasbarrini G | |
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment | 2006 | C. Giannini; F. Giannelli; A.L. Zignego | |
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia | 2008 | C. Giannini; A. Petrarca; M. Monti; U. Arena; P. Caini; V. Solazzo; L. Gragnani; S. Milani; G. Laffi; A.L. Zignego | |
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment | 2002 | F. Giannelli; M. Monti; P. Caini; S. Moscarella; R.G. Romanelli; C. Giannini; L. Gragnani; G. La Villa; G. Laffi; P. Gentilini; A.L. Zignego | |
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? | 2005 | A. Petrarca; U. Arena; C. Giannini; M. Monti; V. Solazzo; F. Giannelli; P. Caini; G. La Villa; G. Laffi; A.L. Zignego | |
Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues | 2001 | Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Brechot P; Brechot C; Kremsdorf D | |
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? | 2008 | C. Giannini; L. Gragnani; A. Piluso; P. Caini; A. Petrarca; M. Monti; G. Laffi; A.L. Zignego | |
Can depletion of B-cells by anti-CD20 monoclonal antibody in HCV plus mixed cryoglobulinemia (MC) improve liver cirrhosis? | 2007 | A. Petrarca; L. Rigacci; C. Giannini; R. Caporale; P. Montalto; A. Bosi; G. Laffi; A.L. Zignego | |
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION | 2001 | P. Caini; A. Mazzocca; C. Cordella; C. Giannini; P. Pantaleo; R.G. Romanelli; M. E. Marrocchi; G. Laffi; P. Gentilini; A.L. Zignego. | |
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression | 2001 | P. Caini; A. Mazzocca; C. Cordella; C. Giannini; P. Pantaleo; R.G. Romanelli; M.E. Marrocchi; G. Laffi; P. Gentilini; A.L. Zignego | |
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression | 2001 | P. Caini; A. Mazzocca; C. Giannini; P. Pantaleo; R.G. Romanelli; L. Gragnani; G. Laffi; P. Gentilini; A.L. Zignego | |
Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells. Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells | 1991 | Capaccioli S.; Quattrone A.; Basi G.; Schiavone N.; Giannini C. | |
Chronic hepatitis C and B-cell non-Hodgkin's lymphoma | 1996 | C. Ferri; L. La Civita; M. Monti; C. Giannini; R. Cecchetti; F. Caracciolo; G.Longombardo; F.Lombardini; A.L. Zignego; | |
Clustering of the putative hepatitis C virus (HCV) receptor CD81 is necessary to promote B-cell proliferation and c-myc expression. | 2000 | A. Mazzocca; C. Cordella; C. Giannini; P. Pantaleo; R.G. Romanelli; G. Laffi; P. Gentilini; A.L. Zignego | |
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. | 2000 | A. Mazzocca; F. Giannelli; R.G. Romanelli; S. Moscarella; P. Caini; C. Giannini; M. Monti; G. La Villa; G. Laffi. P. Gentilini; A.L. Zignego. |